Literature DB >> 16597902

Nosocomial bacteremia due to an as yet unclassified acinetobacter genomic species 17-like strain.

Jesús Rodriguez-Baño1, Sara Martí, Anna Ribera, Felipe Fernández-Cuenca, Lenie Dijkshoorn, Alexandr Nemec, Miquel Pujol, Jordi Vila.   

Abstract

We describe a case of bacteremia due to an as yet unclassified Acinetobacter genomic species 17-like strain. The recognition of this microorganism as non-Acinetobacter baumannii may have important epidemiological implications, as it relieves the hospital of the implementation of barrier precautions for patients infected or colonized as may be necessary with a multiresistant A. baumannii epidemic.

Entities:  

Mesh:

Year:  2006        PMID: 16597902      PMCID: PMC1448640          DOI: 10.1128/JCM.44.4.1587-1589.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Bacteremia caused by Acinetobacter ursingii.

Authors:  Julien Loubinoux; Liliana Mihaila-Amrouche; Anne Le Fleche; Etienne Pigne; Gerard Huchon; Patrick A D Grimont; Anne Bouvet
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Delineation of new proteolytic genomic species in the genus Acinetobacter.

Authors:  P J Bouvet; S Jeanjean
Journal:  Res Microbiol       Date:  1989 May-Jun       Impact factor: 3.992

3.  Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.

Authors:  A Nemec; T De Baere; I Tjernberg; M Vaneechoutte; T J van der Reijden; L Dijkshoorn
Journal:  Int J Syst Evol Microbiol       Date:  2001-09       Impact factor: 2.747

4.  Reliability of phenotypic tests for identification of Acinetobacter species.

Authors:  P Gerner-Smidt; I Tjernberg; J Ursing
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

5.  Recognition of two novel phenons of the genus Acinetobacter among non-glucose-acidifying isolates from human specimens.

Authors:  A Nemec; L Dijkshoorn; P Jezek
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals.

Authors:  Jesús Rodríguez-Baño; Jose M Cisneros; Felipe Fernández-Cuenca; Anna Ribera; Jordi Vila; Alvaro Pascual; Luis Martínez-Martínez; German Bou; Jerónimo Pachón
Journal:  Infect Control Hosp Epidemiol       Date:  2004-10       Impact factor: 3.254

7.  Seven novel species of Acinetobacter isolated from activated sludge.

Authors:  Emma L Carr; Peter Kämpfer; Bharat K C Patel; Volker Gürtler; Robert J Seviour
Journal:  Int J Syst Evol Microbiol       Date:  2003-07       Impact factor: 2.747

8.  Identification and biotyping of clinical isolates of Acinetobacter.

Authors:  P J Bouvet; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Sep-Oct

9.  Septicemia due to Acinetobacter junii.

Authors:  Hans-Jörg Linde; Joachim Hahn; Ernst Holler; Udo Reischl; Norbert Lehn
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens.

Authors:  Alexandr Nemec; Lenie Dijkshoorn; Ilse Cleenwerck; Thierry De Baere; Danielle Janssens; Tanny J K van der Reijden; Petr Ježek; Mario Vaneechoutte
Journal:  Int J Syst Evol Microbiol       Date:  2003-09       Impact factor: 2.747

View more
  2 in total

1.  Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens.

Authors:  Laurent Dortet; Patrick Legrand; Claude-James Soussy; Vincent Cattoir
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

2.  The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequences.

Authors:  Marie Touchon; Jean Cury; Eun-Jeong Yoon; Lenka Krizova; Gustavo C Cerqueira; Cheryl Murphy; Michael Feldgarden; Jennifer Wortman; Dominique Clermont; Thierry Lambert; Catherine Grillot-Courvalin; Alexandr Nemec; Patrice Courvalin; Eduardo P C Rocha
Journal:  Genome Biol Evol       Date:  2014-10-13       Impact factor: 3.416

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.